This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
October 21 - 23, 2024
Presented in Japan Standard Time

The Westin Miyako Kyoto
Delivered as a Hybrid Event

Dr. Robert Pejchal, PhD
Vice President, Antibody Engineering at Adimab
Speaker

Profile

Dr. Pejchal received his PhD from University of Michigan Ann Arbor in protein crystallography. He then did a postdoc at The Scripps Research Institute where he studied broadly neutralizing HIV-1 antibodies, solved crystal structures of such antibodies bound to viral envelope glycoproteins and peptide antigens. After taking a scientist position at Adimab LLC, his focus on antibody engineering blossomed into a bispecific antibody discovery and optimization and cell selection approaches for membrane protein targets. Currently, as VP of Antibody Engineering, his work on bispecifics and membrane protein targets continues alongside platform optimization, antibody format research and development, and developability.